These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15654813)

  • 21. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
    Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG
    Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
    Ramanathan S; Gagnon J; Ilangumaran S
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
    Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
    Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A
    Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.
    Landmeier S; Altvater B; Pscherer S; Eing BR; Kuehn J; Rooney CM; Juergens H; Rossig C
    Cancer Res; 2007 Sep; 67(17):8335-43. PubMed ID: 17804749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic engineering of T cell specificity for immunotherapy of cancer.
    Willemsen RA; Debets R; Chames P; Bolhuis RL
    Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells.
    van Loenen MM; de Boer R; Hagedoorn RS; Jankipersadsing V; Amir AL; Falkenburg JH; Heemskerk MH
    Gene Ther; 2013 Aug; 20(8):861-7. PubMed ID: 23364317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.
    Bobisse S; Zanovello P; Rosato A
    Expert Opin Biol Ther; 2007 Jun; 7(6):893-906. PubMed ID: 17555374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer.
    Ochi T; Fujiwara H; Yasukawa M
    Expert Opin Biol Ther; 2011 Jun; 11(6):699-713. PubMed ID: 21413911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term functionality of TCR-transduced T cells in vivo.
    Coccoris M; Swart E; de Witte MA; van Heijst JW; Haanen JB; Schepers K; Schumacher TN
    J Immunol; 2008 May; 180(10):6536-43. PubMed ID: 18453572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric T-cell receptors for the targeting of cancer cells.
    Rössig C; Brenner MK
    Acta Haematol; 2003; 110(2-3):154-9. PubMed ID: 14583676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy II: Antigens, receptors and costimulation.
    Searle PF; Young LS
    Cancer Metastasis Rev; 1996 Sep; 15(3):329-49. PubMed ID: 9034595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer.
    Kageyama S; Ikeda H; Miyahara Y; Imai N; Ishihara M; Saito K; Sugino S; Ueda S; Ishikawa T; Kokura S; Naota H; Ohishi K; Shiraishi T; Inoue N; Tanabe M; Kidokoro T; Yoshioka H; Tomura D; Nukaya I; Mineno J; Takesako K; Katayama N; Shiku H
    Clin Cancer Res; 2015 May; 21(10):2268-77. PubMed ID: 25855804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal T-cell receptors: new reagents for cancer therapy.
    Stauss HJ; Cesco-Gaspere M; Thomas S; Hart DP; Xue SA; Holler A; Wright G; Perro M; Little AM; Pospori C; King J; Morris EC
    Mol Ther; 2007 Oct; 15(10):1744-50. PubMed ID: 17637721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life or death of T cells with antigen-specific receptors--using T cells for cancer adoptive immunotherapy/gene therapy.
    Ren-Heidenreich L; Lum LG
    Curr Gene Ther; 2001 Sep; 1(3):253-5. PubMed ID: 12109140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.
    Stauss HJ; Thomas S; Cesco-Gaspere M; Hart DP; Xue SA; Holler A; King J; Wright G; Perro M; Pospori C; Morris E
    Blood Cells Mol Dis; 2008; 40(1):113-6. PubMed ID: 17855129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.